CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated C... (Atherosclerosis Atherosclerosis is th...)

CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol

Date:11/9/2007

Atherosclerosis

Atherosclerosis is the progressive buildup of plaque -- the fatty deposits and other cells -- in the inner walls of the arteries. The condition is a consequence of elevated cholesterol and for many it's a silent disease, with no visible signs or symptoms. The disease can begin in early adulthood and continues to progress for the rest of a person's life. Despite the serious nature of atherosclerosis, many people do not understand how it develops and progresses.

About CRESTOR

CRESTOR is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, nonHDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. CRESTOR is also indicated as an adjunct to diet to slow the progression of atherosclerosis in adult patients as part of a treatment strategy to lower Total-C and LDL-C to target levels. CRESTOR has not been determined to prevent heart disease, heart attacks, or strokes. For patients with hypercholesterolemia and mixed dyslipidemia, the usual recommended starting dose of CRESTOR is 10 mg. The 40-mg dose of CRESTOR is reserved only for those patients who have not achieved their LDL-C goal utilizing the 20-mg dose of CRESTOR once daily. When initiating statin therapy or switching from another statin therapy, the appropriate CRESTOR starting dose should first be utilized, and only then titrated according to the patient's individualized goal of therapy. AstraZeneca licensed worldwide rights to CRESTOR from the Japanese pharmaceutical company Shionogi & Co., Ltd.

For more information about CRESTOR, including full Prescribing Information, visit http://www.crestor.com .

Important Safety Information

CRESTOR is contraindicated in patients with a known hypersensitivity to any component of the product and in patients with active liver disease or unexplained persistent elevations of hepatic transamin
'/>"/>

4

GOOD

Page: 1 2 3 4
Related medicine news :

1. Brain Lesions Predict MS Progression
2. Pregnancy may slow -- not accelerate -- progression to AIDS
3. Progression of SIV infection in monkeys raises
4. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
5. Limiting refined carbohydrates may stall AMD progression
6. New Data Suggests Progression of Disability at Two Years Predicts Multiple Sclerosis (MS) Disability Progression at Eight Years
7. Study finds genetic influence on pace of HIV/AIDS progression
8. Lifetime trauma may speed progression of HIV, early death
9. A new mathematical formula for cancer progression
10. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
11. Comparison of obstetric outcomes between on-call and patients own obstetricians

Post Your Comments:

CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated C...(Atherosclerosis Atherosclerosis is th...),Health